Customized vaccine selectively targets toxic amyloid-beta oligomers TORONTO, Ontario and CAMBRIDGE, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases,… Read More..

BOULDER, CO / ACCESSWIRE / March 22, 2022 / Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), developer of a proprietary AI platform for audio and innovative technologies for podcasts that is reinventing how consumers engage with radio, announced today that Jeff Thramann, founder and executive chairman of Auddia has… Read More..

Conference Call onThursday, March 24, 2022 at 4:00pm ET / 1:00pm PT San Francisco, CA, March 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today… Read More..